Return to the Latest

Supreme Court Rules to Continue Access to Medication Abortion

June 13, 2024
Contact: Emma Bittner
(972) 510-3395 |

Supreme Court Rules to Continue Access to Medication Abortion

(Washington, DC) –  Today, the Supreme Court of the United States ruled in an unanimous decision to reject the challenge to the FDA’s approval to widely distribute Mifepristone, the initial pill in a two-pill regimen used for medication abortions, as the case lacked legal standing. This monumental decision is the first SCOTUS ruling regarding abortion following the overturning of Roe v Wade in 2022.

Mifepristone, a safe and widely utilized medication, has shifted towards online prescription and mail delivery since becoming more accessible in 2016. Continuing to allow widespread access to Mifepristone is critical for future abortion and miscarriage care as reproductive rights remain under attack, but also for the future of the FDA’s authority and its approved medications.

As a result, Mifepristone will remain widely available. 

In response, Kristin McGuire, Executive Director at Young Invincibles, said: 

“Abortion care is health care. Mifepristone is essential for continued access to abortion and miscarriage care, especially in states with restricted and near-total bans on access to abortion. This ruling comes after continued attacks against reproductive health have decimated access to care all over the country.

We are pleased that the Court ruled in support of the continued widespread access to Mifepristone and medication abortions. Now, more than ever, it is crucial to support legislation and policies that protect and expand reproductive rights and ensure that all individuals have access to comprehensive health care, regardless of where they live. We must continue to advocate for access to safe abortion for all who need it.”


Young Invincibles (YI) is a national advocacy and policy nonprofit organization focused on amplifying the voice of young people in the political process at the local, state, and federal levels. YI focuses on issues impacting young adults ages 18 to 34 in higher education, health care, economic security, and civic engagement. Our offices include Washington, D.C., California, Colorado, Illinois, New York, and Texas. For more information, please contact Emma Bittner at (972) 510-3395 or